TY  - GEN
AU  - Chen,Wen
AU  - Ward,Thomas
AU  - Tan,Mai Ping
AU  - Yan,Jing
AU  - Wang,Peter Feng
AU  - Wygant,Gail D
AU  - Gordon,Jason
TI  - Daclatasvir combined with asunaprevir is a cost-effective and cost-saving treatment for hepatitis C infection in China
SN  - 2042-6313
PY  - 2019///1101
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Carbamates
KW  - China
KW  - Cost-Benefit Analysis
KW  - Drug Therapy, Combination
KW  - Genotype
KW  - Health Expenditures
KW  - Health Resources
KW  - economics
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Imidazoles
KW  - Isoquinolines
KW  - Life Expectancy
KW  - Male
KW  - Markov Chains
KW  - Models, Econometric
KW  - Pyrrolidines
KW  - Quality-Adjusted Life Years
KW  - Sulfonamides
KW  - Valine
KW  - analogs & derivatives
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.2217/cer-2018-0005
ER  -